✍️ 🧑‍🦱 💚 Autor:innen verdienen bei uns doppelt. Dank euch haben sie so schon 418.243 € mehr verdient. → Mehr erfahren 💪 📚 🙏

Novel Developments in Stem Cell Mobilization

Softcover - 9781489993762
160,49 €
  • Versandkostenfrei
Auf meine Merkliste
  • Hinweis: Print on Demand. Lieferbar in 2 Tagen.
  • Lieferzeit nach Versand: ca. 1-2 Tage
  • inkl. MwSt. & Versandkosten (innerhalb Deutschlands)

Weitere Formate

Hardcover - 9781461419594
160,49 €

Autorenfreundlich Bücher kaufen?!

Weitere Formate

Hardcover - 9781461419594
160,49 €

Beschreibung

Recently the CXCR4/CXCL12-axis has been recognized as one of the pivotal adhesion pathways by which hematopoietic stem cells are retained in the bone marrow. CXCR4 antagonists with different chemical specification are being developed. Pharmacology research guides the way to the rational development effective antagonists. One antagonist, plerixafor, is clinically approved now for stem cell mobilization of lymphoma and myeloma patients. This allows patients to receive potentially life-saving treatment which could not have been administered otherwise. Through early clinical studies it was recognized that CXCR4 antagonists also mobilize malignant hematopoetic cells, i.e. leukemia cells. In preclinical studies a sensitization of mobilized leukemic cells to standard cytotoxic chemotherapy could be shown. Clinical studies are under way. CXCR4 antagonists are an exciting new class of compounds which are also employed for the mobilization of angiogenic cells or for the treatment of solid tumors. In this book a concise review of the current status of knowledge and future developments will be presented.

Focus on CXCR4

Focus on CXCR4

Details

Verlag Springer US
Ersterscheinung 12. April 2014
Maße 23.5 cm x 15.5 cm
Gewicht 768 Gramm
Format Softcover
ISBN-13 9781489993762
Auflage 2012
Seiten 498

Herstellerinformationen +

Widerrufsantrag einreichen

Füllen Sie das folgende Formular aus, um Ihren Widerrufsantrag einzureichen.